COVID-19 and Goodwill Impairment on IFRS and U.S. GAAP

Please join Duff & Phelps experts from across the globe in a discussion of how the coronavirus pandemic has affected goodwill impairment testing.

Register Now

Schedule: 11:00 a.m. (Brazil time) / 10:00 a.m. (ET)

Topics

• Background on how the COVID-19 economic environment is impacting goodwill impairment testing
• Identifying triggering events and deciding whether an impairment test is appropriate
• Adjusting cash flow projections
• Selecting discount rate assumptions
• Addressing stock market price fluctuations and reconciling value conclusions
• Highlighting similarities and differences between U.S. GAAP and IFRS

Speakers

• Eduardo Luque, Managing Director, Irko
• Greg Franceschi, Managing Director, Valuation Services and Global Head of the Financial Reporting Practice and Office of Professional Practice
• Carla Nunes, Managing Director, Valuation Digital Solutions and Office of Professional Practice
• Nicolas Ballian, Managing Director, Valuation Services
• Alexandre Pierantoni, Managing Director, Corporate Finance